Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |